Deanne Miller
Chief Operating Officer bei IMMUTEP LIMITED
Vermögen: 809 998 $ am 31.03.2024
Profil
Deanne Miller is currently the Co-Managing Director at Immutep GmbH and the COO, Secretary & General Counsel at Immutep Ltd.
She is also a Member of The Law Society of New South Wales.
Previously, she worked as an Associate Director at Westpac Banking Corp., a Manager-Legal & Compliance at Macquarie Group Ltd., and a Legal Counsel at RBC Investor Services Trust (Australia).
Ms. Miller completed her undergraduate and graduate degrees at The University of Sydney.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUTEP LTD
0,27% | 22.08.2023 | 3 267 305 ( 0,27% ) | 809 998 $ | 31.03.2024 |
Aktive Positionen von Deanne Miller
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUTEP LIMITED | Chief Operating Officer | 01.11.2016 |
| The Law Society of New South Wales | Corporate Officer/Principal | - |
Immutep GmbH
 Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Deanne Miller
| Unternehmen | Position | Ende |
|---|---|---|
| MACQUARIE GROUP LIMITED | Compliance Officer | - |
| RBC Investor Services Trust (Australia) | General Counsel | - |
| WESTPAC BANKING CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Deanne Miller
| The University of Sydney | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| WESTPAC BANKING CORPORATION | Finance |
| IMMUTEP LIMITED | Health Technology |
| MACQUARIE GROUP LIMITED | Finance |
| Private Unternehmen | 3 |
|---|---|
| The Law Society of New South Wales | |
| RBC Investor Services Trust (Australia) | Finance |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Health Technology |
